Viz.ai Adds PE Stratification | Liver Cancer Blood Test

5th September 2022 – Contribution by Sanjay Parekh – Featured on ImagingWire.com

Viz.ai is So On-Trend – Signify Research recently forecast that AI leaders will increasingly expand into new clinical segments, enhance their current solutions, and leverage platform / marketplace strategies, as AI evolves from point solutions to comprehensive workflows. Those trends are certainly evident within Viz.ai’s recent PE strategy.